Genotoxic-activated G2-M checkpoint exit is dependent on CDC25B phosphatase expression. - Université Toulouse III - Paul Sabatier - Toulouse INP Accéder directement au contenu
Article Dans Une Revue Molecular Cancer Therapeutics Année : 2006

Genotoxic-activated G2-M checkpoint exit is dependent on CDC25B phosphatase expression.

Résumé

Cell cycle arrest at the G2-M checkpoint is an essential feature of the mechanisms that preserve genomic integrity. CDC25 phosphatases control cell cycle progression by dephosphorylating and activating cyclin-dependent kinase/cyclin complexes. Their activities are, therefore, tightly regulated to modulate cell cycle arrest in response to DNA damage exposure. Here, we report that overexpression of CDC25B affects viability, reduces clonogenic efficiency, and increases sensitivity of cancer cells to a genotoxic agent. We show that ectopic expression of CDC25B results in bypass of a genotoxic-induced G2-M checkpoint. In addition, cancer cells constitutively expressing high level of CDC25B are shown to be prone to exit prematurely from the G2-M checkpoint arrest and to enter mitosis. Finally, we show that this exit is dependent on CDC25B expression. Together with previous results, our data strongly support a model in which CDC25B is the key phosphatase that controls entry into mitosis after DNA damage, thus emphasizing the relevance of its overexpression in many human tumors.
Fichier non déposé

Dates et versions

hal-00317382 , version 1 (03-09-2008)

Identifiants

Citer

Béatrix Bugler, Muriel Quaranta, Bernadette Aressy, Marie-Christine Brezak, Grégoire Prevost, et al.. Genotoxic-activated G2-M checkpoint exit is dependent on CDC25B phosphatase expression.. Molecular Cancer Therapeutics, 2006, 5 (6), pp.1446-51. ⟨10.1158/1535-7163.MCT-06-0099⟩. ⟨hal-00317382⟩
55 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More